[go: up one dir, main page]

AU7217891A - Therapeutic agents, and intermediates for the synthesis thereof - Google Patents

Therapeutic agents, and intermediates for the synthesis thereof

Info

Publication number
AU7217891A
AU7217891A AU72178/91A AU7217891A AU7217891A AU 7217891 A AU7217891 A AU 7217891A AU 72178/91 A AU72178/91 A AU 72178/91A AU 7217891 A AU7217891 A AU 7217891A AU 7217891 A AU7217891 A AU 7217891A
Authority
AU
Australia
Prior art keywords
intermediates
synthesis
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72178/91A
Inventor
Jonathan Miles-Brown
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
OXFORD VIROLOGY PLC
Original Assignee
OXFORD VIROLOGY PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909003257A external-priority patent/GB9003257D0/en
Priority claimed from GB909006500A external-priority patent/GB9006500D0/en
Application filed by OXFORD VIROLOGY PLC filed Critical OXFORD VIROLOGY PLC
Publication of AU7217891A publication Critical patent/AU7217891A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/642Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a cytokine, e.g. IL2, chemokine, growth factors or interferons being the inactive part of the conjugate
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU72178/91A 1990-02-13 1991-02-13 Therapeutic agents, and intermediates for the synthesis thereof Abandoned AU7217891A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9003257 1990-02-13
GB909003257A GB9003257D0 (en) 1990-02-13 1990-02-13 Therapeutic agents and intermediates for the synthesis thereof
GB909006500A GB9006500D0 (en) 1990-03-23 1990-03-23 Therapeutic agents,and intermediates for the synthesis thereof
GB9006500 1990-03-23

Publications (1)

Publication Number Publication Date
AU7217891A true AU7217891A (en) 1991-09-03

Family

ID=26296657

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72178/91A Abandoned AU7217891A (en) 1990-02-13 1991-02-13 Therapeutic agents, and intermediates for the synthesis thereof

Country Status (2)

Country Link
AU (1) AU7217891A (en)
WO (1) WO1991012021A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1079805E (en) * 1998-04-27 2005-03-31 Opperbas Holding Bv PHARMACEUTICAL COMPOSITION UNDERSTANDING FACTOR VIII AND NEUTRAL LIPOSOMES

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE151638T1 (en) * 1987-02-20 1997-05-15 Genentech Inc METHODS AND PREPARATIONS FOR USE OF HIV ENV POLYPEPTIDES AND ANTIBODIES
PT88641B (en) * 1987-10-02 1993-04-30 Genentech Inc METHOD FOR PREPARING A VARIETY OF ADHESION
ZA893284B (en) * 1988-05-04 1990-03-28 Igen Inc Peptide analogs and their use as haptens to elicit catalytic antibodies
DK0470184T3 (en) * 1989-04-25 1997-03-10 Tanox Biosystems Inc Specific antibodies for the CD4-binding domain in HIV

Also Published As

Publication number Publication date
WO1991012021A2 (en) 1991-08-22
WO1991012021A3 (en) 1991-12-12

Similar Documents

Publication Publication Date Title
AU656157B2 (en) Pharmaceutical agents
AU7122291A (en) 3-arylcarbonyl-1h-indoles useful as therapeutic agents
AU3888793A (en) Novel medicament
AU9089591A (en) Inhaler
AU8751391A (en) Inhaler
HU9302460D0 (en) 5/20/4-(1,2-benzisothiazole-3-yl)-1-pierazinyl/ethyl/-6-chlorine-1,3-dihydro-2h-indole-2-one-hydrogen-chloride-mononhydrate
AU2805195A (en) Therapeutic compounds
AU3284395A (en) Synthesis of 1,1,1,3,3,-pentafluoropropane
AU8043491A (en) Fungicides
AU7957791A (en) Portable golf-sack
AU8212891A (en) Equine herpesvirus-4 tk-vaccine
AU6386390A (en) Therapeutic necleosides
AU1140197A (en) Pyridyl carbamates, process and intermediates for the preparation and use thereof
AU3263493A (en) Tonometer
AU7719791A (en) Therapeutic product
AU639825B2 (en) Substituted 1,2,4-triazinediones, processes for their preparation, intermediates therefor and their use
AU2547895A (en) Therapeutic phenoxyalkylheterocycles
AU5371694A (en) Use of the tarchonanthus camphoratus
AU8043891A (en) Fungicides
EP0445827A3 (en) 4-hydroxytetrahydropyran-2-one derivatives and intermediates for synthesizing the same
AU6594690A (en) Therapeutic agents
AU2402392A (en) New anti-diarrheic agents
AU7217891A (en) Therapeutic agents, and intermediates for the synthesis thereof
AU4762993A (en) Keratometer
AU7442791A (en) Massage arrangement